Literature DB >> 4031826

Kinetics of synthesis of respiratory syncytial virus glycoproteins.

B F Fernie, G Dapolito, P J Cote, J L Gerin.   

Abstract

The synthesis of the two respiratory syncytial (RS) virus glycoproteins (VP66 and VP84) was examined under standard conditions and after treatment with tunicamycin and monensin. The protein backbone for VP66, the fusion protein (F1,2) is cotranslationally glycosylated to form F0, which is cleaved to form F1,2 by 20 min of chase. Monensin treatment inhibited the cleavage of F0 over an 80 min chase period, indicating that this occurred late in the transit of F0 through the Golgi apparatus or after exit from the Golgi apparatus. Tunicamycin treatment resulted in the synthesis of a 50K to 55K unglycosylated F0 which is cleaved to a 40K protein. VP84, the large glycoprotein, contains a protein backbone of only 26K to 30K which is modified by N-linked and probable O-linked glycosylation. Tunicamycin treatment results in the synthesis of a 70K protein (p70) which incorporates [3H]glucosamine and [3H]fucose but not [3H]mannose. Glycosylated precursors varying in mol. wt. from 29K to 45K (p45) are found in infected cells at regular 2K to 3K intervals, producing a 'ladder' effect. The step from p45 to VP84 is severely delayed by monensin treatment thereby enhancing the 'ladder' effect of the precursors.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4031826     DOI: 10.1099/0022-1317-66-9-1983

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  13 in total

Review 1.  Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy--a review.

Authors:  Yechiel Becker
Journal:  Virus Genes       Date:  2006-10       Impact factor: 2.332

2.  O glycosylation of glycoprotein G of human respiratory syncytial virus is specified within the divergent ectodomain.

Authors:  P L Collins
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

3.  The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins.

Authors:  P R Johnson; M K Spriggs; R A Olmsted; P L Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

4.  Interprotein disulfide bonding between F and G glycoproteins of human respiratory syncytial virus.

Authors:  R G Arumugham; S W Hildreth; P R Paradiso
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

5.  Further characterization of the soluble form of the G glycoprotein of respiratory syncytial virus.

Authors:  D A Hendricks; K McIntosh; J L Patterson
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

6.  Resistance to human respiratory syncytial virus (RSV) infection induced by immunization of cotton rats with a recombinant vaccinia virus expressing the RSV G glycoprotein.

Authors:  N Elango; G A Prince; B R Murphy; S Venkatesan; R M Chanock; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

7.  Identification of linear heparin-binding peptides derived from human respiratory syncytial virus fusion glycoprotein that inhibit infectivity.

Authors:  Roberta L Crim; Susette A Audet; Steven A Feldman; Howard S Mostowski; Judy A Beeler
Journal:  J Virol       Date:  2006-10-18       Impact factor: 5.103

8.  Structure and cell surface maturation of the attachment glycoprotein of human respiratory syncytial virus in a cell line deficient in O glycosylation.

Authors:  G W Wertz; M Krieger; L A Ball
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

9.  Evolutionary pattern of human respiratory syncytial virus (subgroup A): cocirculating lineages and correlation of genetic and antigenic changes in the G glycoprotein.

Authors:  O García; M Martín; J Dopazo; J Arbiza; S Frabasile; J Russi; M Hortal; P Perez-Breña; I Martínez; B García-Barreno
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

10.  Respiratory syncytial virus grown in Vero cells contains a truncated attachment protein that alters its infectivity and dependence on glycosaminoglycans.

Authors:  Steven Kwilas; Rachael M Liesman; Liqun Zhang; Edward Walsh; Raymond J Pickles; Mark E Peeples
Journal:  J Virol       Date:  2009-08-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.